The test’s ability to distinguish ALS from similar conditions is particularly noteworthy. It could help physicians differentiate between ALS and conditions that mimic its symptoms, such as primary ...

According to recent research, astrocyte cell transplantation could revolutionize treatments for neurological disorders such ...

Three patients in the UK are part of a trial for a new treatment for the chronic disease lupus with the aim of reducing their need to take medication. Lupus is an autoimmune disease for which there is ...

Q3 2024 Earnings Call Transcript November 9, 2024 Operator: Greetings, and welcome to the Achieve Life Sciences Third Quarter ...

I opened the calendar on my phone and confirmed that there were 38 days until my son’s bar mitzvah. If only I could have one day, I thought — a day in a normal body. My son’s bar mitzvah is a symbolic ...

Abu Dhabi, UAE: Sheikh Shakhbout Medical City (SSMC), one of the UAE’s largest hospitals for serious and complex care and a ...

Unicycive, which is seeking an FDA green light for oxylanthanum carbonate to treat hyperphosphatemia in patients with chronic kidney disease who are on dialysis, Monday said the agency set a target ...

Colon cancer patient achieved stable disease and remained on study for more than six months, breast cancer patient remained on study for more than 11 monthsBiomarker analysis confirms immune activatio ...

Neurizon Therapeutics Limited (ASX: NUZ & NUZOA) ("Neurizon" or "the Company"), a clinical-stage biotech company advancing ...

Aptevo Therapeutics and Alligator Bioscience report favorable safety, tolerability and evidence of biological activity of ALG.APV-527, more than half of evaluable patients achieved stable diseaseColon ...

Early results from a trial of the company’s Lunit SCOPE system found patients examined with the device saw a 35% lower risk ...